Back to results
US 2026/0242469 A1Published application
Anti-cd2 antibodies for amyotrophic lateral sclerosis
AssigneeZelarion Malta Limited
InventorsErik BERGLUND, David BERGLUND, Alan Slade
Life of this patent
Estimating the term…
Abstract
Provided herein is an anti-CD2 antibody or antigen binding fragment thereof for treating and/or preventing ALS in a subject in need thereof.
Claims54
A method of treating, preventing or ameliorating at least one symptom associated with amyotrophic lateral sclerosis (ALS) in a subject in need thereof, wherein the method comprises administering to the subject an effective amount of a recombinant anti-CD2 antibody or an antigen binding fragment thereof.
Dependencies are inferred from the claim text.